This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Negotiating a New Agreement (C): Mindy Fitzgerald-Owner of the Milwaukee Bobcats
Ann C. Frost; Justin PattersonCase IVEY-9B21C031-ELeadership and People ManagementSupplement for product 9B21C029.Starting at €5.74
-
Negotiating a New Agreement: The NFLPA and NFL Owners (A, B, C, D, E, F & G) - Teaching Note
Ann C. Frost; Justin PattersonTeaching Note IVEY-8B21C029-ELeadership and People ManagementTeaching note for product 9B21C029.Starting at €0.00
-
Dunia Finance LLC (A), (B), and (C) - Teaching Note
Venkatesan, Rajkumar; Bodily, Samuel E.; Yemen, Gerry; Gibbs, SheaTeaching Note DARDEN-M-0842TN-EMarketingTeaching note for product M-0842Starting at €0.00
-
Negotiating a New Agreement (D): Mike Donaldson-Safety, Blue Mountain Goats
Ann C. Frost; Justin PattersonCase IVEY-9B21C032-ELeadership and People ManagementSupplement for product 9B21C029.Starting at €5.74
-
Negotiating a New Agreement (G): John Jackson -Owner of the Compton Clovers
Ann C. Frost; Justin PattersonCase IVEY-9B21C035-ELeadership and People ManagementSupplement for product 9B21C029.Starting at €8.20
-
Negotiating a New Agreement (E): Marcus Tatum-Owner of the San Antonio Sharks
Ann C. Frost; Justin PattersonCase IVEY-9B21C033-ELeadership and People ManagementSupplement for product 9B21C029.Starting at €5.74
-
Negotiating a New Agreement (B): Robert Williams-Quarterback for the Metropolis Knights
Ann C. Frost; Justin PattersonCase IVEY-9B21C030-ELeadership and People ManagementSupplement for product 9B21C029.Starting at €5.74
-
Negotiating a New Agreement (F): Lawrence Bell-Running Back for the Gotham Rogues
Ann C. Frost; Justin PattersonCase IVEY-9B21C034-ELeadership and People ManagementSupplement for product 9B21C029.Starting at €5.74
-
Merck & Company: Product KL-798
Frey, Sherwood C. Jr.; Bodily, Samuel E.Case DARDEN-QA-0582-EDecision AnalysisMerck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.Starting at €8.20
-
Airbus and Boeing: Superjumbo Decisions
Bodily, Samuel E.; Lichtendahl, Kenneth C. Jr.Case DARDEN-QA-0720-EDecision AnalysisSet in 1999, this case allows students to put themselves in the positions of both Airbus and Boeing as Boeing considered how to respond to Airbus's decision to announce its plans to proceed or not with the $10 billion development of the world's first commercial superjumbo jet, the Airbus A3XX. Boeing was considering a development effort to "stretch" its 747 jumbo jet into a larger superjumbo version, the 747-X. At the time, the two companies' wid...Starting at €8.20